IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 281, Issue 2 44-2, 2001, Pages

  Andress, Dennis L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Bone formation; Bone mineral density; Estrogen deficiency

Indexed keywords

ESTROGEN; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MATRIX; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMUR; HORMONAL REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OVARIECTOMY; PRIORITY JOURNAL; SPINE;

EID: 0034885967     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.281.2.e283     Document Type: Article

References (27)

1. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells
2. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor
3. A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells
4. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
5. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy
6. Carboxytruncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells
7. High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse
8. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone
9. Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation
10. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis
11. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
12. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones
13. Enhanced osteoblast proliferation and collagen gene expression by estradiol
14. Estradiol stimulates the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR 106
15. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β
16. 2, growth hormone, and the insulin-like growth factors
17. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
18. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
19. Recombinant human insulin-like growth factor binding protein-5 stimulates bone formation parameters in vitro and in vivo
20. Mechanical loading, estrogen deficiency, and the coupling of bone formation and bone resorption
21. Is high-dose estrogen-induced osteogenesis in the mouse mediated by the estrogen receptor?
22. High-dose estrogen induces medullary bone formation in female mice
23. Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures
24. Growth hormone (GH) receptor activity is stimulated by insulin-like growth factor binding protein (IGFBP)-5 in rat osteosarcoma cells
25. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
26. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy
27. Targeted over-expression of insulin-like growth factor-I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation